These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22863358)

  • 1. Is primary prevention of Clostridium difficile infection possible with specific probiotics?
    Johnson S; Maziade PJ; McFarland LV; Trick W; Donskey C; Currie B; Low DE; Goldstein EJ
    Int J Infect Dis; 2012 Nov; 16(11):e786-92. PubMed ID: 22863358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
    McFarland LV; Ship N; Auclair J; Millette M
    J Hosp Infect; 2018 Aug; 99(4):443-452. PubMed ID: 29702133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fascination with probiotics for Clostridium difficile infection: lack of evidence for prophylactic or therapeutic efficacy.
    Miller M
    Anaerobe; 2009 Dec; 15(6):281-4. PubMed ID: 19699309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics and prevention of Clostridium difficile infection.
    Goldstein EJC; Johnson SJ; Maziade PJ; Evans CT; Sniffen JC; Millette M; McFarland LV
    Anaerobe; 2017 Jun; 45():114-119. PubMed ID: 27988389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Clostridium difficile Infection With Probiotics.
    Evans CT; Johnson S
    Clin Infect Dis; 2015 May; 60 Suppl 2():S122-8. PubMed ID: 25922397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic.
    Hell M; Bernhofer C; Stalzer P; Kern JM; Claassen E
    Benef Microbes; 2013 Mar; 4(1):39-51. PubMed ID: 23434948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Probiotic for Primary Prevention of Clostridium difficile Infection: A Single-Center Before-and-After Quality Improvement Intervention at a Tertiary-Care Medical Center.
    Trick WE; Sokalski SJ; Johnson S; Bunnell KL; Levato J; Ray MJ; Weinstein RA
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):765-770. PubMed ID: 29695310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
    Maziade PJ; Pereira P; Goldstein EJ
    Clin Infect Dis; 2015 May; 60 Suppl 2():S144-7. PubMed ID: 25922400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.
    McFarland LV
    Anaerobe; 2009 Dec; 15(6):274-80. PubMed ID: 19825425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections.
    McFarland LV
    Benef Microbes; 2015; 6(2):189-94. PubMed ID: 24889895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Jul; 41(7):1212-21. PubMed ID: 17595306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics for prevention and treatment of diarrhea.
    Guandalini S
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative therapies for Clostridium difficile infections.
    Venuto C; Butler M; Ashley ED; Brown J
    Pharmacotherapy; 2010 Dec; 30(12):1266-78. PubMed ID: 21114394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
    Auclair J; Frappier M; Millette M
    Clin Infect Dis; 2015 May; 60 Suppl 2():S135-43. PubMed ID: 25922399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
    Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM
    Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis.
    Pattani R; Palda VA; Hwang SW; Shah PS
    Open Med; 2013; 7(2):e56-67. PubMed ID: 24348885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics in clostridium difficile Infection.
    Na X; Kelly C
    J Clin Gastroenterol; 2011 Nov; 45 Suppl(Suppl):S154-8. PubMed ID: 21992956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis.
    Shen NT; Maw A; Tmanova LL; Pino A; Ancy K; Crawford CV; Simon MS; Evans AT
    Gastroenterology; 2017 Jun; 152(8):1889-1900.e9. PubMed ID: 28192108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
    McFarland LV
    Am J Gastroenterol; 2006 Apr; 101(4):812-22. PubMed ID: 16635227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.